Brachytherapy boost for T1/T2 nasopharyngeal carcinoma
2009 · Head & Neck · 19 citations
https://doi.org/10.1002/hed.21130
K
Kam Weng Fong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
78
Papers
2.0K
Citations
18
h-index
23
i10-index
Kam Weng Fong is an academic researcher from National Cancer Centre Singapore. The author has contributed to research in topics: Head and Neck Cancer Studies & Lung Cancer Diagnosis and Treatment & Lung Cancer Treatments and Mutations. The author has an h-index of 18, co-authored 67 publications.
ORCID: 0000-0001-9745-3687Papers by this author
worksWeak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01)
2009 · Radiation Oncology · 10 citations
https://doi.org/10.1186/1748-717x-4-23
Proceedings of the 7th Biannual International Symposium on Nasopharyngeal Carcinoma 2015
2016 · BMC Proceedings · 3 citations
https://doi.org/10.1186/s12919-016-0001-5
The impact of the COVID-19 pandemic on nasopharyngeal carcinoma patients – a national cancer centre experience
2023 · Holistic Integrative Oncology · 1 citations
https://doi.org/10.1007/s44178-023-00041-0
P109-7 Defining a group of oligometastatic nasopharyngeal carcinoma patients with improved survival outcomes
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.07.504
Tumor immune microenvironment delineates progression trajectories of distinct nasopharyngeal carcinoma phenotypes
2025 · Cell Reports Medicine · 0 citations
https://doi.org/10.1016/j.xcrm.2025.102143
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat